Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs712829

Current Build 156

Released September 21, 2022

Organism
Homo sapiens
Position
chr7:55019062 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
G>C / G>T
Variation Type
SNV Single Nucleotide Variation
Frequency
T=0.278832 (73804/264690, TOPMED)
T=0.04072 (1150/28240, 14KJPN)
T=0.04000 (670/16750, 8.3KJPN) (+ 14 more)
T=0.10920 (1230/11264, ALFA)
T=0.2264 (1134/5008, 1000G)
T=0.2750 (1231/4476, Estonian)
T=0.3246 (1251/3854, ALSPAC)
T=0.3042 (1128/3708, TWINSUK)
T=0.0397 (111/2796, KOREAN)
T=0.0358 (63/1762, Korea1K)
T=0.282 (169/600, NorthernSweden)
T=0.296 (162/548, PharmGKB)
T=0.398 (86/216, Qatari)
G=0.398 (70/176, SGDP_PRJ)
T=0.33 (13/40, GENOME_DK)
G=0.50 (10/20, Siberian)
T=0.50 (10/20, Siberian)
Clinical Significance
Reported in ClinVar
Gene : Consequence
EGFR : 5 Prime UTR Variant
LOC105375284 : 2KB Upstream Variant
Publications
17 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20230706150541
Population Group Sample Size Ref Allele Alt Allele
Total Global 11264 G=0.89080 C=0.00000, T=0.10920
European Sub 8706 G=0.8591 C=0.0000, T=0.1409
African Sub 1678 G=1.0000 C=0.0000, T=0.0000
African Others Sub 74 G=1.00 C=0.00, T=0.00
African American Sub 1604 G=1.0000 C=0.0000, T=0.0000
Asian Sub 100 G=1.00 C=0.00, T=0.00
East Asian Sub 78 G=1.00 C=0.00, T=0.00
Other Asian Sub 22 G=1.00 C=0.00, T=0.00
Latin American 1 Sub 62 G=1.00 C=0.00, T=0.00
Latin American 2 Sub 392 G=1.000 C=0.000, T=0.000
South Asian Sub 56 G=1.00 C=0.00, T=0.00
Other Sub 270 G=0.989 C=0.000, T=0.011


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
TopMed Global Study-wide 264690 G=0.721168 T=0.278832
14KJPN JAPANESE Study-wide 28240 G=0.95928 T=0.04072
8.3KJPN JAPANESE Study-wide 16750 G=0.96000 T=0.04000
Allele Frequency Aggregator Total Global 11264 G=0.89080 C=0.00000, T=0.10920
Allele Frequency Aggregator European Sub 8706 G=0.8591 C=0.0000, T=0.1409
Allele Frequency Aggregator African Sub 1678 G=1.0000 C=0.0000, T=0.0000
Allele Frequency Aggregator Latin American 2 Sub 392 G=1.000 C=0.000, T=0.000
Allele Frequency Aggregator Other Sub 270 G=0.989 C=0.000, T=0.011
Allele Frequency Aggregator Asian Sub 100 G=1.00 C=0.00, T=0.00
Allele Frequency Aggregator Latin American 1 Sub 62 G=1.00 C=0.00, T=0.00
Allele Frequency Aggregator South Asian Sub 56 G=1.00 C=0.00, T=0.00
1000Genomes Global Study-wide 5008 G=0.7736 T=0.2264
1000Genomes African Sub 1322 G=0.7549 T=0.2451
1000Genomes East Asian Sub 1008 G=0.9415 T=0.0585
1000Genomes Europe Sub 1006 G=0.6899 T=0.3101
1000Genomes South Asian Sub 978 G=0.699 T=0.301
1000Genomes American Sub 694 G=0.791 T=0.209
Genetic variation in the Estonian population Estonian Study-wide 4476 G=0.7250 T=0.2750
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 3854 G=0.6754 T=0.3246
UK 10K study - Twins TWIN COHORT Study-wide 3708 G=0.6958 T=0.3042
KOREAN population from KRGDB KOREAN Study-wide 2796 G=0.9603 T=0.0397
Korean Genome Project KOREAN Study-wide 1762 G=0.9642 T=0.0358
Northern Sweden ACPOP Study-wide 600 G=0.718 T=0.282
PharmGKB Aggregated Global Study-wide 548 G=0.704 T=0.296
PharmGKB Aggregated PA156031064 Sub 156 G=0.673 T=0.327
PharmGKB Aggregated PA133885305 Sub 138 G=0.768 T=0.232
PharmGKB Aggregated PA133886766 Sub 138 G=0.768 T=0.232
PharmGKB Aggregated PA156070583 Sub 116 G=0.595 T=0.405
Qatari Global Study-wide 216 G=0.602 T=0.398
SGDP_PRJ Global Study-wide 176 G=0.398 T=0.602
The Danish reference pan genome Danish Study-wide 40 G=0.68 T=0.33
Siberian Global Study-wide 20 G=0.50 T=0.50
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 7 NC_000007.14:g.55019062G>C
GRCh38.p14 chr 7 NC_000007.14:g.55019062G>T
GRCh37.p13 chr 7 NC_000007.13:g.55086755G>C
GRCh37.p13 chr 7 NC_000007.13:g.55086755G>T
EGFR RefSeqGene (LRG_304) NG_007726.3:g.5031G>C
EGFR RefSeqGene (LRG_304) NG_007726.3:g.5031G>T
Gene: EGFR, epidermal growth factor receptor (plus strand)
Molecule type Change Amino acid[Codon] SO Term
EGFR transcript variant 1 NM_005228.5:c.-216= N/A 5 Prime UTR Variant
EGFR transcript variant 6 NM_001346898.2:c.-216= N/A 5 Prime UTR Variant
EGFR transcript variant EGFRvIII NM_001346941.2:c.-216= N/A 5 Prime UTR Variant
EGFR transcript variant 4 NM_201284.2:c.-216= N/A 5 Prime UTR Variant
EGFR transcript variant 2 NM_201282.2:c.-216= N/A 5 Prime UTR Variant
EGFR transcript variant 5 NM_001346897.2:c.-216= N/A 5 Prime UTR Variant
EGFR transcript variant 7 NM_001346899.2:c.-216= N/A 5 Prime UTR Variant
EGFR transcript variant 3 NM_201283.2:c.-216= N/A 5 Prime UTR Variant
EGFR transcript variant 8 NM_001346900.2:c. N/A Genic Upstream Transcript Variant
EGFR transcript variant X1 XM_047419952.1:c. N/A Genic Upstream Transcript Variant
EGFR transcript variant X2 XM_047419953.1:c. N/A Genic Upstream Transcript Variant
Gene: LOC105375284, uncharacterized LOC105375284 (minus strand) : 2KB Upstream Variant
Molecule type Change Amino acid[Codon] SO Term
LOC105375284 transcript variant X3 XR_007060329.1:n. N/A Upstream Transcript Variant
LOC105375284 transcript variant X1 XR_007060328.1:n. N/A N/A
LOC105375284 transcript variant X2 XR_927272.3:n. N/A N/A
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: T (allele ID: 303193 )
ClinVar Accession Disease Names Clinical Significance
RCV001656223.2 not provided Benign
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement G= C T
GRCh38.p14 chr 7 NC_000007.14:g.55019062= NC_000007.14:g.55019062G>C NC_000007.14:g.55019062G>T
GRCh37.p13 chr 7 NC_000007.13:g.55086755= NC_000007.13:g.55086755G>C NC_000007.13:g.55086755G>T
EGFR RefSeqGene (LRG_304) NG_007726.3:g.5031= NG_007726.3:g.5031G>C NG_007726.3:g.5031G>T
EGFR transcript variant 1 NM_005228.5:c.-216= NM_005228.5:c.-216G>C NM_005228.5:c.-216G>T
EGFR transcript variant 1 NM_005228.4:c.-216= NM_005228.4:c.-216G>C NM_005228.4:c.-216G>T
EGFR transcript variant 1 NM_005228.3:c.-216= NM_005228.3:c.-216G>C NM_005228.3:c.-216G>T
EGFR transcript variant 7 NM_001346899.2:c.-216= NM_001346899.2:c.-216G>C NM_001346899.2:c.-216G>T
EGFR transcript variant 7 NM_001346899.1:c.-216= NM_001346899.1:c.-216G>C NM_001346899.1:c.-216G>T
EGFR transcript variant EGFRvIII NM_001346941.2:c.-216= NM_001346941.2:c.-216G>C NM_001346941.2:c.-216G>T
EGFR transcript variant EGFRvIII NM_001346941.1:c.-216= NM_001346941.1:c.-216G>C NM_001346941.1:c.-216G>T
EGFR transcript variant 6 NM_001346898.2:c.-216= NM_001346898.2:c.-216G>C NM_001346898.2:c.-216G>T
EGFR transcript variant 6 NM_001346898.1:c.-216= NM_001346898.1:c.-216G>C NM_001346898.1:c.-216G>T
EGFR transcript variant 5 NM_001346897.2:c.-216= NM_001346897.2:c.-216G>C NM_001346897.2:c.-216G>T
EGFR transcript variant 5 NM_001346897.1:c.-216= NM_001346897.1:c.-216G>C NM_001346897.1:c.-216G>T
EGFR transcript variant 4 NM_201284.2:c.-216= NM_201284.2:c.-216G>C NM_201284.2:c.-216G>T
EGFR transcript variant 4 NM_201284.1:c.-216= NM_201284.1:c.-216G>C NM_201284.1:c.-216G>T
EGFR transcript variant 2 NM_201282.2:c.-216= NM_201282.2:c.-216G>C NM_201282.2:c.-216G>T
EGFR transcript variant 2 NM_201282.1:c.-216= NM_201282.1:c.-216G>C NM_201282.1:c.-216G>T
EGFR transcript variant 3 NM_201283.2:c.-216= NM_201283.2:c.-216G>C NM_201283.2:c.-216G>T
EGFR transcript variant 3 NM_201283.1:c.-216= NM_201283.1:c.-216G>C NM_201283.1:c.-216G>T
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

58 SubSNP, 18 Frequency, 1 ClinVar submissions
No Submitter Submission ID Date (Build)
1 TSC-CSHL ss76412 Oct 04, 2000 (86)
2 LEE ss1550730 Oct 04, 2000 (86)
3 SC_JCM ss6026346 Feb 20, 2003 (111)
4 EGP_SNPS ss24778532 Sep 20, 2004 (126)
5 ABI ss42884772 Mar 10, 2006 (126)
6 PHARMGKB_PAAR-UCHI ss69366397 May 18, 2007 (127)
7 PHARMGKB_PAAR-UCHI ss69366408 May 18, 2007 (127)
8 PHARMGKB_PAAR-UCHI ss105110072 Feb 04, 2009 (130)
9 PHARMGKB_PAAR-UCHI ss105110077 Feb 04, 2009 (130)
10 COMPLETE_GENOMICS ss162353835 Jul 04, 2010 (132)
11 BCM-HGSC-SUB ss208461409 Jul 04, 2010 (132)
12 1000GENOMES ss233988294 Jul 15, 2010 (132)
13 SSMP ss654383244 Apr 25, 2013 (138)
14 EVA-GONL ss984301832 Aug 21, 2014 (142)
15 1000GENOMES ss1325212973 Aug 21, 2014 (142)
16 EVA_GENOME_DK ss1582213556 Apr 01, 2015 (144)
17 EVA_UK10K_ALSPAC ss1618259666 Apr 01, 2015 (144)
18 EVA_UK10K_TWINSUK ss1661253699 Apr 01, 2015 (144)
19 WEILL_CORNELL_DGM ss1927545459 Feb 12, 2016 (147)
20 JJLAB ss2024459443 Sep 14, 2016 (149)
21 USC_VALOUEV ss2152655313 Dec 20, 2016 (150)
22 GNOMAD ss2853364430 Nov 08, 2017 (151)
23 SWEGEN ss3001151043 Nov 08, 2017 (151)
24 ILLUMINA ss3022737487 Nov 08, 2017 (151)
25 BIOINF_KMB_FNS_UNIBA ss3026026126 Nov 08, 2017 (151)
26 CSHL ss3347597123 Nov 08, 2017 (151)
27 ILLUMINA ss3653270030 Oct 12, 2018 (152)
28 EGCUT_WGS ss3669076596 Jul 13, 2019 (153)
29 EVA_DECODE ss3719735671 Jul 13, 2019 (153)
30 ACPOP ss3734652529 Jul 13, 2019 (153)
31 EVA ss3766592241 Jul 13, 2019 (153)
32 PACBIO ss3785824095 Jul 13, 2019 (153)
33 PACBIO ss3791125433 Jul 13, 2019 (153)
34 PACBIO ss3796005415 Jul 13, 2019 (153)
35 KHV_HUMAN_GENOMES ss3809752063 Jul 13, 2019 (153)
36 EVA ss3825720143 Apr 26, 2020 (154)
37 EVA ss3830585321 Apr 26, 2020 (154)
38 EVA ss3838782863 Apr 26, 2020 (154)
39 EVA ss3844235276 Apr 26, 2020 (154)
40 SGDP_PRJ ss3867315512 Apr 26, 2020 (154)
41 KRGDB ss3914394125 Apr 26, 2020 (154)
42 KOGIC ss3961505419 Apr 26, 2020 (154)
43 FSA-LAB ss3984367568 Apr 26, 2021 (155)
44 TOPMED ss4746681160 Apr 26, 2021 (155)
45 TOMMO_GENOMICS ss5183235704 Apr 26, 2021 (155)
46 EVA ss5237421713 Apr 26, 2021 (155)
47 1000G_HIGH_COVERAGE ss5272949109 Oct 14, 2022 (156)
48 EVA ss5373691811 Oct 14, 2022 (156)
49 HUGCELL_USP ss5470113903 Oct 14, 2022 (156)
50 HUGCELL_USP ss5470113904 Oct 14, 2022 (156)
51 SANFORD_IMAGENETICS ss5642994671 Oct 14, 2022 (156)
52 TOMMO_GENOMICS ss5723095324 Oct 14, 2022 (156)
53 YY_MCH ss5808621833 Oct 14, 2022 (156)
54 EVA ss5822853701 Oct 14, 2022 (156)
55 EVA ss5848139137 Oct 14, 2022 (156)
56 EVA ss5855905616 Oct 14, 2022 (156)
57 EVA ss5858992024 Oct 14, 2022 (156)
58 EVA ss5972215632 Oct 14, 2022 (156)
59 1000Genomes NC_000007.13 - 55086755 Oct 12, 2018 (152)
60 The Avon Longitudinal Study of Parents and Children NC_000007.13 - 55086755 Oct 12, 2018 (152)
61 Genetic variation in the Estonian population NC_000007.13 - 55086755 Oct 12, 2018 (152)
62 The Danish reference pan genome NC_000007.13 - 55086755 Apr 26, 2020 (154)
63 gnomAD - Genomes

Submission ignored due to conflicting rows:
Row 262051081 (NC_000007.14:55019061:G:C 1/139068)
Row 262051083 (NC_000007.14:55019061:G:T 39709/139026)

- Apr 26, 2021 (155)
64 gnomAD - Genomes

Submission ignored due to conflicting rows:
Row 262051081 (NC_000007.14:55019061:G:C 1/139068)
Row 262051083 (NC_000007.14:55019061:G:T 39709/139026)

- Apr 26, 2021 (155)
65 KOREAN population from KRGDB NC_000007.13 - 55086755 Apr 26, 2020 (154)
66 Korean Genome Project NC_000007.14 - 55019062 Apr 26, 2020 (154)
67 Northern Sweden NC_000007.13 - 55086755 Jul 13, 2019 (153)
68 PharmGKB Aggregated NC_000007.14 - 55019062 Apr 26, 2020 (154)
69 Qatari NC_000007.13 - 55086755 Apr 26, 2020 (154)
70 SGDP_PRJ NC_000007.13 - 55086755 Apr 26, 2020 (154)
71 Siberian NC_000007.13 - 55086755 Apr 26, 2020 (154)
72 8.3KJPN NC_000007.13 - 55086755 Apr 26, 2021 (155)
73 14KJPN NC_000007.14 - 55019062 Oct 14, 2022 (156)
74 TopMed NC_000007.14 - 55019062 Apr 26, 2021 (155)
75 UK 10K study - Twins NC_000007.13 - 55086755 Oct 12, 2018 (152)
76 ALFA NC_000007.14 - 55019062 Apr 26, 2021 (155)
77 ClinVar RCV001656223.2 Oct 14, 2022 (156)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs17288931 Mar 10, 2006 (126)
Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
ss2853364430 NC_000007.13:55086754:G:C NC_000007.14:55019061:G:C (self)
6790258865, ss5470113904 NC_000007.14:55019061:G:C NC_000007.14:55019061:G:C (self)
ss162353835, ss208461409 NC_000007.12:55054248:G:T NC_000007.14:55019061:G:T (self)
37185328, 20740922, 14814844, 8378495, 21571519, 7937394, 9587389, 19332492, 5171667, 41205011, 20740922, ss233988294, ss654383244, ss984301832, ss1325212973, ss1582213556, ss1618259666, ss1661253699, ss1927545459, ss2024459443, ss2152655313, ss2853364430, ss3001151043, ss3022737487, ss3347597123, ss3653270030, ss3669076596, ss3734652529, ss3766592241, ss3785824095, ss3791125433, ss3796005415, ss3825720143, ss3830585321, ss3838782863, ss3867315512, ss3914394125, ss3984367568, ss5183235704, ss5237421713, ss5373691811, ss5642994671, ss5822853701, ss5848139137, ss5972215632 NC_000007.13:55086754:G:T NC_000007.14:55019061:G:T (self)
RCV001656223.2, 17883420, 11283, 56932428, 584058719, 6790258865, ss3026026126, ss3719735671, ss3809752063, ss3844235276, ss3961505419, ss4746681160, ss5272949109, ss5470113903, ss5723095324, ss5808621833, ss5855905616, ss5858992024 NC_000007.14:55019061:G:T NC_000007.14:55019061:G:T (self)
ss76412, ss1550730, ss6026346, ss24778532, ss42884772, ss69366397, ss69366408, ss105110072, ss105110077 NT_033968.6:4676123:G:T NC_000007.14:55019061:G:T (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

17 citations for rs712829
PMID Title Author Year Journal
17956637 Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study. Choi JE et al. 2007 BMC cancer
19102716 EGFR-targeted therapies in lung cancer: predictors of response and toxicity. Heist RS et al. 2009 Pharmacogenomics
19190167 A two-stage case-control study of EGFR polymorphisms and breast cancer risk. Hong YS et al. 2009 Cancer epidemiology, biomarkers & prevention
21292812 Functional EGFR germline polymorphisms may confer risk for EGFR somatic mutations in non-small cell lung cancer, with a predominant effect on exon 19 microdeletions. Liu W et al. 2011 Cancer research
22486600 Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab-irinotecan. Etienne-Grimaldi MC et al. 2012 British journal of clinical pharmacology
23927961 Genetic variations in EGFR and ERBB4 increase susceptibility to cervical cancer. Ma D et al. 2013 Gynecologic oncology
23959273 Intergenic polymorphisms in the amphiregulin gene region as biomarkers in metastatic colorectal cancer patients treated with anti-EGFR plus irinotecan. Sebio A et al. 2014 The pharmacogenomics journal
23962910 PharmGKB summary: very important pharmacogene information for the epidermal growth factor receptor. Hodoglugil U et al. 2013 Pharmacogenetics and genomics
24819665 Epidermal growth factor receptor (EGFR) pathway genes and interstitial lung disease: an association study. Li C et al. 2014 Scientific reports
26269114 Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors. Zhang X et al. 2016 Tumour biology
27018053 Progression and metastasis of lung cancer. Popper HH et al. 2016 Cancer metastasis reviews
27897268 Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis. Morgen EK et al. 2017 The pharmacogenomics journal
30011810 The Association between Epidermal Growth Factor Receptor (EGFR) Gene Polymorphisms and Lung Cancer Risk. Bashir NA et al. 2018 Biomolecules
31254173 The Association between Epidermal Growth Factor Receptor Single Nucleotide Polymorphisms and Radiochemotherapy Response in Cervical Cancer. Jin G et al. 2020 Pathology oncology research
32256580 EGFR Polymorphism and Survival of NSCLC Patients Treated with TKIs: A Systematic Review and Meta-Analysis. Jurisic V et al. 2020 Journal of oncology
32780457 Pharmacogenetics for severe adverse drug reactions induced by molecular-targeted therapy. Udagawa C et al. 2020 Cancer science
34070597 Polymorphisms in EGFR Gene Predict Clinical Outcome in Unresectable Non-Small Cell Lung Cancer Treated with Radiotherapy and Platinum-Based Chemoradiotherapy. Butkiewicz D et al. 2021 International journal of molecular sciences
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post774+babeb33